A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer

Tuning the Tumor Myeloid Microenvironment to Fight Cancer

(2019) Nadine S. Jahchan et al.   Frontiers in Immunology

Oncolytic Maraba virus armed with tumor antigen boosts vaccine priming and reveals diverse therapeutic response patterns when combined with checkpoint blockade in ovarian cancer

(2019) A. J. Robert McGray et al.   Journal for ImmunoTherapy of Cancer

Efficient identification of neoantigen-specific T-cell responses in advanced human ovarian cancer

(2019) Song Liu et al.   Journal for ImmunoTherapy of Cancer

Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising?

(2019) Antonio González‐Martín et al.   CANCER

Mechanisms of resistance to immune checkpoint inhibitors

(2018) Russell W Jenkins et al.   BRITISH JOURNAL OF CANCER

PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression

(2018) Haidong Tang et al.   JOURNAL OF CLINICAL INVESTIGATION

Anti-CD27 agonist antibody varlilumab (varli) with nivolumab (nivo) for colorectal (CRC) and ovarian (OVA) cancer: Phase (Ph) 1/2 clinical trial results.

(2018) Rachel E. Sanborn et al.   JOURNAL OF CLINICAL ONCOLOGY

NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer

(2017) J. Brian Szender et al.   GYNECOLOGIC ONCOLOGY

Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer

(2014) K. Odunsi et al.   Cancer Immunology Research

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients

(2012) K. Odunsi et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells

(2009) Eliana Ribechini et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11

(2008) Claus Lundegaard et al.   NUCLEIC ACIDS RESEARCH